SCHEMBL16623509

SCHEMBL16623509

N=C(c1ccc(N2CCOCC2)nc1)c1c(Nc2c(F)cccc2F)cc[nH]c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CNR2 P34972 1/20 0.43
ALDH1A1 P00352 2/20 0.41
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DGAT1 O75907 2/20 0.39
EGFR P00533 1/20 0.39
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
STAT3 P40763 1/20 0.38
MAPK8 P45983 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17849245 0.92 NPC1 (0.41) NPC1RAB9ACNR2ALDH1A1KCNQ3
SCHEMBL17849188 0.87 EGFR (0.40) NPC1RAB9AALDH1A1DGAT1EGFR
SCHEMBL17849216 0.82 AR (0.33) NPC1RAB9AEGFRCCNT1CCNE1
SCHEMBL17849244 0.79 TYK2 (0.40) ALDH1A1KDM4EHPGDHSD17B10EGFR
SCHEMBL17849247 0.79 MAPT (0.41) NPC1RAB9AALDH1A1KDM4EALOX15
SCHEMBL17849249 0.78 EGFR (0.40) ALDH1A1HSD17B10EGFR
SCHEMBL16623493 0.78 TYK2 (0.39)
SCHEMBL16623578 0.77 EGFR (0.35) EGFR
SCHEMBL17849227 0.76 TYK2 (0.42) EGFRHDAC10
SCHEMBL16623478 0.76 PDCD1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed